Compare NMTC & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NMTC | NXPL |
|---|---|---|
| Founded | 2009 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.5M | 25.6M |
| IPO Year | N/A | N/A |
| Metric | NMTC | NXPL |
|---|---|---|
| Price | $0.57 | $0.65 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $2.23 | N/A |
| AVG Volume (30 Days) | ★ 159.1K | 157.9K |
| Earning Date | 12-15-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $6,629,051.00 | ★ $57,151,000.00 |
| Revenue This Year | $162.84 | N/A |
| Revenue Next Year | $26.51 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 69.00 | N/A |
| 52 Week Low | $0.40 | $0.43 |
| 52 Week High | $1.39 | $2.30 |
| Indicator | NMTC | NXPL |
|---|---|---|
| Relative Strength Index (RSI) | 32.46 | 47.25 |
| Support Level | $0.66 | $0.59 |
| Resistance Level | $0.75 | $0.73 |
| Average True Range (ATR) | 0.05 | 0.06 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 4.63 | 55.28 |
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.